Cargando…
Modulation of Tumor Tolerance in Primary Central Nervous System Malignancies
Central nervous system tumors take advantage of the unique immunology of the CNS and develop exquisitely complex stromal networks that promote growth despite the presence of antigen-presenting cells and tumor-infiltrating lymphocytes. It is precisely this immunological paradox that is essential to t...
Autores principales: | Johnson, Theodore S., Munn, David H., Maria, Bernard L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270544/ https://www.ncbi.nlm.nih.gov/pubmed/22312408 http://dx.doi.org/10.1155/2012/937253 |
Ejemplares similares
-
Rare Primary Central Nervous System Tumors
por: Kubicky, Charlotte Dai, et al.
Publicado: (2014) -
Chronic Viral Infection and Primary Central Nervous System Malignancy
por: Saddawi-Konefka, Robert, et al.
Publicado: (2010) -
The use of bevacizumab in primary malignant tumors of the central nervous system: A single-center experience
por: Pehlivan, Metin, et al.
Publicado: (2023) -
Prolactin gene expression in primary central nervous system tumors
por: Mendes, Graziella Alebrant, et al.
Publicado: (2013) -
Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013
por: Walker, Emily V, et al.
Publicado: (2019)